Fertility Drugs & Cancer Risk: What You Need to Know

Recent studies of over 80,000 women show no increased risk of invasive ovarian cancer from fertility drugs, while the American Society for Reproductive Medicine confirms no evidence linking these treatments to breast, endometrial, or other hormone-sensitive cancers.

---

Key Takeaways

Ovarian Cancer Risk and Fertility Treatments

A 2013 study of 80,000 infertile women found no difference in invasive ovarian cancer rates between fertility drug users and non-users. Danish and Cochrane reviews further confirm no increased risk, though borderline tumors show minimal risk variation that lacks conclusive causality.

Breast & Endometrial Cancer and Fertility Medications

Current evidence from multiple studies demonstrates no association between fertility drug use and higher risks of breast or endometrial cancer. Hormonally responsive cancers, including thyroid and melanoma, also show no statistically significant increased risk in patients undergoing fertility treatments.

ASRM Guidelines on Fertility Treatment Safety

The American Society for Reproductive Medicine’s 2016 practice committee guideline provides clinical reassurance that fertility treatments do not elevate cancer risks. This aligns with long-term cohort studies and systematic reviews confirming safety for patients considering infertility interventions.

---

Source: Read full article